Reuters Market Eye - Shares in Sun Pharmaceutical Industries
Currently the drug, Ibandronate Sodium, is marketed by Roche under the brand name Bovina.
"Bovina generated an annual sales of $82 million in 2012. Currently, Sun Pharma is the only generic player to have final approval for this product," brokerage Sharekhan said in a note on Wednesday.
More players would be able to sell the drug after its patent expiry on September 2, 2014, Sharekhan said.
(Reporting by Abhishek Vishnoi)